IDF Diabetes Atlas

Diabetes prevalence, mortality and health expenditure for 2013 and 2035

6th Edition

AcknowledgementsSixth edition committeeNam Han Cho (chair), David Whiting (deputy chair), Leonor Guariguata, Pablo Aschner Montoya, Nita Forouhi, Ian Hambleton, Rui Li, Azeem Majeed, Jean Claude Mbanya, Ayesha Motala, K.M. Venkat Narayan, Ambady Ramachandran, Wolfgang Rathmann, Gojka Roglic, Jonathan Shaw, Martin Silink, D.R.R. Williams, Ping Zhang

Editorial teamLeonor Guariguata, Tim Nolan, Jessica Beagley, Ute Linnenkamp, Olivier Jacqmain

ContributorsFlorencia Aguirre, Alex Brown, Nam Han Cho, Gisela Dahlquist, the Diabetes Education Consultative Section (DECS), Sheree Dodd, Trisha Dunning, Sir Michael Hirst, Christopher Hwang, Dianna Magliano, Chris Patterson, Courtney Scott, Jonathan Shaw, Gyula Soltész, Juliet Usher-Smith

Other ContributorsCarlos Aguilar Salinas, Riyadh Alshamsan, Tabassum Ambia, Carmen Gloria Aylwin, Caroline Baan, Juliana Chan, Adel A El-Sayed, Laercio Franco, Juan José Gagliardino, Jody Grundman, Lucy Hadley, Christian Herder, Hak C. Jang, Pili Kamenju, Andre Pascal Kengne, Tawfik Khoja, Mandana Kooijmans, Silvia Lapertosa, Kerry Lydon, Ronald Ching Wan Ma, Lydia Makaroff, Chris Millett, Graham Ogle, Martijn Parker, Nasheeta Peer, Lorenzo Piemonte, Salman Rawaf, Joachim Rosenbauer, Segundo Seclén, Chamukuttan Snehalatha, Anne Mieke Spijkerman, Teresa Tamayo, Sean Taylor, Sara Webber, Sarah H Wild, Mary Vinocour, Bernard Zinman

Corporate sponsorsIDF would like to express its thanks to the following sponsors for their generous support of the sixth edition:

Supported through an unrestricted grant by the Novo Nordisk Changing Diabetes® initiative

Types of diabetes

Type 1 diabetes Type 2 diabetes Gestational diabetes

• Lack of insulin• Autoimmune• Usually

children

• Insulin resistance

• Lifestyle factors• Usually adults

• Insulin resistance• During pregnancy• Risks to mother

and child

Major diabetes complications• Cardiovascular disease• Eyes• Kidney• Feet

• Fatty liver• Sleep apnea

Co-morbidities

Diabetes is a huge and growing problem, and the costs to society are high and escalating

382 million people have diabetes

By 2035, this number will rise to 592 million

Almost half of all people with diabetes live in just three countries

ChinaIndiaUSA

The socially disadvantaged in any country are especially vulnerable to diabetes

Increasing development

and wealth is correlated

with decreasing

early mortality

due to diabetes

Diabetes is more than a health issue and requires concerted policy action across many sectors